In HF patients, the interleukin-6–hsCRP pathway is significantly activated, leading to increased expression of inducible nitric oxide synthase and reduced cardiac contractility, ultimately resulting in poor short-term prognosis (47, 48). The gene discussed is NOS2; the disease is hydrops fetalis.